INCYTE CORP (INCY)
Services-Commercial Physical & Biological Research
Latest Price
$119.52
TTM P/E
16.88
Normalized P/E
36.49
Div Yield
--
Book Value
28.21
P/B Ratio
4.24
Valuation metrics
adjust assumptions →EPS: $6.41
Book value / share: $26.04
Formula: √(22.5 × EPS × BVPS)
Graham Number
$61.28
49% downside
Norm. op. income: $579M (median of 7yr)
Tax rate: 26%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$38.79
68% downside
Base FCF: $568M (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$65.89
45% downside
EPS: $6.41
Target P/E: 36×
Formula: EPS × P/E
P/E Fair Value
$230.76
+93% upside
Institutional Ownership
97.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 30.74M | $2.89B | 15.38% | +421 | 2026-03-31 |
| BlackRock, Inc. | 18.98M | $1.79B | 9.49% | +650.3K | 2026-03-31 |
| Dodge & Cox | 12.25M | $1.15B | 6.13% | -1.01M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.93M | $1.03B | 5.47% | -- | 2026-03-31 |
| STATE STREET CORP | 9.64M | $907.0M | 4.82% | -15.0K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.76M | $730.0M | 3.88% | -- | 2026-03-31 |
| AQR CAPITAL MANAGEMENT LLC | 5.81M | $536.0M | 2.90% | -912.1K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.70M | $441.0M | 2.35% | -289.8K | 2026-03-31 |
| LSV ASSET MANAGEMENT | 3.92M | $368.0M | 1.96% | -13.7K | 2026-03-31 |
| Invesco Ltd. | 3.87M | $364.0M | 1.94% | +397.0K | 2026-03-31 |